TissGeneSummary for VTCN1 |
Gene summary |
Basic gene information | Gene symbol | VTCN1 |
Gene name | V-set domain containing T cell activation inhibitor 1 | |
Synonyms | B7-H4|B7H4|B7S1|B7X|B7h.5|PRO1291|VCTN1 | |
Cytomap | UCSC genome browser: 1p13.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001253849.1, NM_001253850.1,NM_024626.3,NR_045603.1,NR_045604.1, | |
Description | B7 family member, H4B7 homolog 4B7 superfamily member 1T cell costimulatory molecule B7xT-cell costimulatory molecule B7xV-set domain-containing T-cell activation inhibitor 1immune costimulatory protein B7-H4 | |
Modification date | 20141207 | |
dbXrefs | MIM : 608162 | |
HGNC : HGNC | ||
Ensembl : ENSG00000134258 | ||
HPRD : 06429 | ||
Vega : OTTHUMG00000012118 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_VTCN1 | |
BioGPS: 79679 | ||
Pathway | NCI Pathway Interaction Database: VTCN1 | |
KEGG: VTCN1 | ||
REACTOME: VTCN1 | ||
Pathway Commons: VTCN1 | ||
Context | iHOP: VTCN1 | |
ligand binding site mutation search in PubMed: VTCN1 | ||
UCL Cancer Institute: VTCN1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | BreastOvary | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | BRCAOV | |
Reference showing the relevant tissue of VTCN1 | ||
Description by TissGene annotations | Cancer gene Have significant anti-correlated miRNA Fused withOncogene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for VTCN1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
THCA | -0.047388927 | -3.513509266 | 3.466120339 | 1.21E-10 | 7.93E-10 |
LUSC | 2.501846998 | -0.677482413 | 3.179329412 | 2.38E-08 | 7.18E-08 |
PRAD | 0.533509932 | 2.538742624 | -2.005232692 | 6.60E-07 | 4.88E-06 |
KICH | -2.044996453 | 4.752007547 | -6.797004 | 4.79E-19 | 2.71E-17 |
LIHC | -1.614034453 | 1.485191547 | -3.099226 | 2.54E-08 | 2.02E-07 |
KIRC | -1.372697119 | 5.061415381 | -6.4341125 | 3.57E-41 | 1.57E-39 |
KIRP | 2.472785172 | 5.007419547 | -2.534634375 | 1.72E-07 | 1.01E-06 |
COAD | -3.22910353 | -4.301518914 | 1.072415385 | 0.00141 | 0.003920444 |
LUAD | 1.216779892 | -0.595258039 | 1.812037931 | 5.17E-05 | 0.000135947 |
Top |
TissGene-miRNA for VTCN1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
ACC | hsa-miR-382-3p | MIMAT0022697 | 0.0054 | -0.32 | 78 |
ACC | hsa-miR-382-3p | MIMAT0022697 | 0.0054 | -0.32 | 78 |
Top |
TissGeneMut for VTCN1 |
TissGeneSNV for VTCN1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.F266L | LIHC | 1 |
p.T38S | HNSC | 1 |
p.S256L | SKCM | 1 |
p.R116W | GBM | 1 |
p.S65C | BLCA | 1 |
p.E92Q | BLCA | 1 |
p.F96L | READ | 1 |
p.R100G | BLCA | 1 |
p.R116Q | ESCA | 1 |
p.E85K | SKCM | 1 |
p.T41A | KIRP | 1 |
p.R100Q | STAD | 1 |
p.V120M | LUAD | 1 |
p.L115S | LGG | 1 |
p.P175S | SKCM | 1 |
p.S269I | GBM | 1 |
p.D230N | SKCM | 1 |
p.L25F | SKCM | 1 |
p.S3F | SKCM | 1 |
p.N220S | SKCM | 1 |
p.D135N | SKCM | 1 |
p.E82A | COAD | 1 |
p.S148L | COAD | 1 |
p.S192L | LUAD | 1 |
p.F191L | PAAD | 1 |
p.R172* | PRAD | 1 |
p.S135C | HNSC | 1 |
p.E59K | SKCM | 1 |
p.R248Q | SARC | 1 |
p.D189N | CESC | 1 |
p.G148E | SKCM | 1 |
Top |
TissGeneCNV for VTCN1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for VTCN1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | BRCA | TCGA-E9-A244-01A | VTCN1-NUP88 | Out-of-Frame | chr1:117695712 | chr17:5292280 |
Chimerdb3.0 | TopHat-Fusion | BRCA | TCGA-E9-A244-01A | VTCN1-NUP88 | Out-of-Frame | chr1:117695712 | chr17:5292279 |
TCGAfusionPortal | PRADA | BRCA | TCGA-E9-A244-01A | VTCN1-NUP88 | Out-of-frame | Chr1:117695713 | Chr17:5292280 |
TCGAfusionPortal | PRADA | OV | TCGA-29-1785-01A | VTCN1-PTGFRN | Out-of-frame | Chr1:117753446 | Chr1:117484337 |
Top |
TissGeneNet for VTCN1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for VTCN1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for VTCN1 |
TissGeneDrug for VTCN1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for VTCN1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0006142 | Malignant neoplasm of breast | 7 | BeFree,GAD |
umls:C0178874 | Tumor Progression | 7 | BeFree |
umls:C0678222 | Breast Carcinoma | 7 | BeFree |
umls:C0024623 | Malignant neoplasm of stomach | 4 | BeFree |
umls:C0029925 | Ovarian Carcinoma | 4 | BeFree |
umls:C1140680 | Malignant neoplasm of ovary | 4 | BeFree |
umls:C1519680 | Tumor Immunity | 4 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 3 | BeFree,LHGDN |
umls:C0235974 | Pancreatic carcinoma | 3 | BeFree |
umls:C0346647 | Malignant neoplasm of pancreas | 3 | BeFree |
umls:C0699791 | Stomach Carcinoma | 3 | BeFree |
umls:C0003873 | Rheumatoid Arthritis | 2 | BeFree |
umls:C0011847 | Diabetes | 2 | BeFree |
umls:C0011849 | Diabetes Mellitus | 2 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
umls:C0596263 | Carcinogenesis | 2 | BeFree |
umls:C0919267 | ovarian neoplasm | 2 | LHGDN |
umls:C3495559 | Juvenile arthritis | 2 | BeFree,GAD |
umls:C3714757 | Juvenile rheumatoid arthritis | 2 | BeFree |
umls:C0001418 | Adenocarcinoma | 1 | BeFree |
umls:C0003864 | Arthritis | 1 | GWASCAT |
umls:C0004364 | Autoimmune Diseases | 1 | BeFree |
umls:C0007847 | Malignant tumor of cervix | 1 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 1 | BeFree |
umls:C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | BeFree |
umls:C0014859 | Esophageal Neoplasms | 1 | BeFree |
umls:C0017661 | IGA Glomerulonephritis | 1 | BeFree |
umls:C0019159 | Hepatitis A | 1 | BeFree |
umls:C0022658 | Kidney Diseases | 1 | BeFree |
umls:C0024143 | Lupus Nephritis | 1 | BeFree |
umls:C0025202 | melanoma | 1 | BeFree |
umls:C0026764 | Multiple Myeloma | 1 | BeFree |
umls:C0027697 | Nephritis | 1 | BeFree |
umls:C0029463 | Osteosarcoma | 1 | BeFree |
umls:C0085110 | Severe Combined Immunodeficiency | 1 | BeFree |
umls:C0086445 | Idiopathic Membranous Glomerulonephritis | 1 | BeFree |
umls:C0152018 | Esophageal carcinoma | 1 | BeFree |
umls:C0206692 | Carcinoma, Lobular | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
umls:C0302592 | Cervix carcinoma | 1 | BeFree |
umls:C0546837 | Malignant neoplasm of esophagus | 1 | BeFree |
umls:C0585442 | Osteosarcoma of bone | 1 | BeFree |
umls:C0677886 | Epithelial ovarian cancer | 1 | BeFree |
umls:C0684249 | Carcinoma of lung | 1 | BeFree |
umls:C0686619 | Secondary malignant neoplasm of lymph node | 1 | BeFree |
umls:C0887833 | Carcinoma, Pancreatic Ductal | 1 | LHGDN |
umls:C1176475 | Ductal Carcinoma | 1 | BeFree |
umls:C1271104 | Blood pressure finding | 1 | GAD |
umls:C1272641 | Systemic arterial pressure | 1 | GAD |
umls:C1335302 | Pancreatic Ductal Adenocarcinoma | 1 | BeFree |
umls:C1336076 | Sporadic Breast Carcinoma | 1 | BeFree |
umls:C1512981 | Mammary Tumorigenesis | 1 | BeFree |
umls:C1527249 | Colorectal Cancer | 1 | BeFree |
umls:C3549742 | Breast cancer, lobular | 1 | BeFree |